ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 99 filers reported holding ADAMAS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.92 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,366,000 | -75.1% | 159,924 | -41.5% | 0.16% | -71.6% |
| Q3 2018 | $5,477,000 | -35.4% | 273,593 | -16.6% | 0.55% | -36.8% |
| Q2 2018 | $8,477,000 | +69.2% | 328,193 | +56.5% | 0.87% | +40.5% |
| Q1 2018 | $5,010,000 | -78.7% | 209,644 | -69.7% | 0.62% | -80.5% |
| Q4 2017 | $23,483,000 | +21.2% | 692,913 | -24.3% | 3.17% | +28.3% |
| Q3 2017 | $19,371,000 | +200.8% | 915,000 | +148.5% | 2.47% | +167.4% |
| Q2 2017 | $6,439,000 | +137.3% | 368,166 | +137.5% | 0.92% | +115.1% |
| Q1 2017 | $2,713,000 | +23.5% | 155,000 | +19.2% | 0.43% | +2.1% |
| Q4 2016 | $2,197,000 | -99.9% | 130,000 | 0.0% | 0.42% | +24.2% |
| Q3 2016 | $2,133,300,000 | +108299.4% | 130,000 | 0.0% | 0.34% | -2.9% |
| Q2 2016 | $1,968,000 | – | 130,000 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,423,578 | $8,826,000 | 6.08% |
| Healthcare Value Capital, LLC | 200,000 | $1,240,000 | 2.33% |
| ARMISTICE CAPITAL, LLC | 2,700,000 | $16,740,000 | 1.06% |
| DELTEC ASSET MANAGEMENT LLC | 550,836 | $3,415,000 | 0.75% |
| Broadfin Capital, LLC | 441,088 | $2,735,000 | 0.60% |
| Kerrisdale Advisers, LLC | 229,347 | $1,422,000 | 0.51% |
| Worth Venture Partners, LLC | 87,908 | $545,000 | 0.30% |
| Mosaic Family Wealth, LLC | 91,314 | $566,000 | 0.24% |
| EMERALD ADVISERS, LLC | 700,176 | $4,341,000 | 0.17% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 616,664 | $3,823,000 | 0.15% |